Intuitive Surgical, Inc. (ISRG) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Buy
Based on 55 analysts47.0% Below Target
ISRG trades 47.0% below Wall Street's consensus target of $597.78.
Current Price$406.78
Average Target$597.78
Target
Current
Low$525.00
Median$580.00
High$750.00
Analyst Target Range
Forward P/E38.9x
(Growth Premium)
PEG Ratio1.79
(Fair)
Implied Growth+26.2%
(High Growth)
Analyst Spread37.6%
(Moderate)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes ISRG achieves its forward estimates and maintains a stable P/E multiple of 38.9x. This scenario reflects the blended consensus of 55 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
ISRG Price Target Analysis
Updated June 21, 2026As of June 21, 2026, Intuitive Surgical, Inc. (ISRG) has a Wall Street consensus price target of $597.78, based on estimates from 55 covering analysts. With the stock currently trading at $406.78, this represents a potential upside of +47.0%. The company has a market capitalization of $144.48B.
Analyst price targets range from a low of $525.00 to a high of $750.00, representing a 38% spread in expectations. The median target of $580.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 38 analysts rating the stock as a Buy or Strong Buy,12 rating it Hold, and 5 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ISRG trades at a trailing P/E of 51.7x and forward P/E of 38.9x. The forward PEG ratio of 1.79 indicates reasonable valuation for growth. Analysts expect EPS to grow +26.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $491.89, with bear and bull scenarios of $309.89 and $648.12 respectively. Model confidence stands at 63/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+44.5%
Industry Consensus
Avg Forward P/E
99.5x
(High Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 SYKStryker Corporation | $117.9B | $307.80 | $387.46 | +25.9% | Buy | 20.5x | 51 |
 MDTMedtronic plc | $101.9B | $79.34 | $95.80 | +20.7% | Buy | 13.3x | 51 |
 BSXBoston Scientific Corporation | $67.3B | $45.29 | $82.90 | +83.0% | Buy | 13.5x | 44 |
 ZBHZimmer Biomet Holdings, Inc. | $17.2B | $87.97 | $96.33 | +9.5% | Hold | 10.4x | 42 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $78.69 | +3.5% | Hold | 17.2x | 42 |
 NVCRNovoCure Limited | $1.6B | $14.28 | $33.00 | +131.1% | Buy | — | 15 |
 GMEDGlobus Medical, Inc. | $10.7B | $79.23 | $109.50 | +38.2% | Buy | 16.7x | 36 |
 ATRCAtriCure, Inc. | $1.5B | $28.80 | $51.33 | +78.2% | Buy | 768.0x | 19 |
 ABTAbbott Laboratories | $153.7B | $88.38 | $127.46 | +44.2% | Buy | 16.1x | 41 |
 JNJJohnson & Johnson | $550.4B | $228.39 | $251.55 | +10.1% | Buy | 19.7x | 40 |
ISRG — Frequently Asked Questions
Quick answers to the most common questions about buying ISRG stock.
What is the ISRG stock price target for 2026?
The consensus Wall Street price target for ISRG is $597.78, representing 47.0% upside from the current price of $406.78. With 55 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is ISRG a buy, sell, or hold?
ISRG has a consensus rating of "Buy" based on 55 Wall Street analysts. The rating breakdown is predominantly bullish, with 38 Buy/Strong Buy ratings. The consensus 12-month price target of $597.78 implies 47.0% upside from current levels.
Is ISRG stock overvalued or undervalued?
At a forward P/E of 38.9405x, ISRG trades at a premium valuation. The consensus price target of $597.78 (47.0% upside) suggests analysts still see growth justifying the multiple.
How high can ISRG stock go?
The most bullish Wall Street analyst has a price target of $750 for ISRG, while the most conservative target is $525. The consensus of $597.78 represents the median expectation. Our quantitative valuation model projects a bull case target of $648 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover ISRG stock?
ISRG is heavily covered by Wall Street, with 55 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 38 have Buy ratings, 12 recommend Hold, and 5 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ISRG stock forecast?
The 12-month ISRG stock forecast based on 55 Wall Street analysts shows a consensus price target of $597.78, with estimates ranging from $525 (bear case) to $750 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $492, with bear/bull scenarios of $310/$648.
What is ISRG's fair value based on fundamentals?
Our quantitative valuation model calculates ISRG's fair value at $492 (base case), with a bear case of $310 and bull case of $648. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 63/100.
What is ISRG's forward P/E ratio?
ISRG trades at a forward P/E ratio of 38.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 51.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ISRG stock?
Wall Street analysts are very optimistic on ISRG, with a "Buy" consensus rating and $597.78 price target (47.0% upside). 38 of 55 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ISRG price targets vary so much?
ISRG analyst price targets range from $525 to $750, a 38% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $597.78 consensus represents the middle ground. Our model's $310-$648 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into ISRG consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare